Trials / Unknown
UnknownNCT00253799
A Safety Study of Hylan GF-20 to Treat Shoulder Osteoarthritis
Prospective, Single Arm, Pilot Study Evaluating the Safety and Efficacy of Hyaluronan (Hylan GF-20) in Patients With Painful Shoulder Osteoarthritis
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 35 (estimated)
- Sponsor
- Northwestern Ophthalmic Institute S.C. · Academic / Other
- Sex
- All
- Age
- 35 Years
- Healthy volunteers
- Accepted
Summary
The objective is to assess the safety and efficacy (over the course of 26 weeks) of 2 intra-articular (IA) Hylan GF-20 (Synvisc) injections in addition to customary care in patients with painful glenohumeral osteoarthritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hylan GF-20 |
Timeline
- Start date
- 2005-12-01
- First posted
- 2005-11-15
- Last updated
- 2007-06-25
Source: ClinicalTrials.gov record NCT00253799. Inclusion in this directory is not an endorsement.